Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Robb

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Heart Journal|October 3, 2003
N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failureR S Gardner, F Ozalp, A J Murday, et al.
Heart (British Cardiac Society)|August 19, 2003
The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart diseaseS Campbell, D K George, S D Robb, et al.
Heart (British Cardiac Society)|February 21, 1998
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceD R Murdoch, J Byrne, J J Morton, et al.
European Heart Journal|January 14, 1999
Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992D R Murdoch, M P Love, S D Robb, et al.
Lancet (London, England)|January 20, 1998
Biochemical detection of left-ventricular systolic dysfunctionT A McDonagh, S D Robb, D R Murdoch, et al.
British Journal of Cancer|March 5, 2009
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoringA L Jones, M Barlow, P J Barrett-Lee, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Heart Journal|October 3, 2003
N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failureR S Gardner, F Ozalp, A J Murday, et al.
Heart (British Cardiac Society)|August 19, 2003
The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart diseaseS Campbell, D K George, S D Robb, et al.
Heart (British Cardiac Society)|February 21, 1998
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceD R Murdoch, J Byrne, J J Morton, et al.
European Heart Journal|January 14, 1999
Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992D R Murdoch, M P Love, S D Robb, et al.
Lancet (London, England)|January 20, 1998
Biochemical detection of left-ventricular systolic dysfunctionT A McDonagh, S D Robb, D R Murdoch, et al.
British Journal of Cancer|March 5, 2009
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoringA L Jones, M Barlow, P J Barrett-Lee, et al.
Pageof 1